On Monday, Shares of Mylan N.V. (NASDAQ:MYL), lost -1.14% to $73.05.
Mylan, declared that its partner, Mylan Pharmaceuticals Private Limited, has launched Gilead Sciences’ Sovaldi (sofosbuvir 400mg tablets) in India. Sovaldi is indicated for the treatment of chronic hepatitis C infection, a blood-borne infectious disease, as a component of a combination antiviral treatment regimen. It is estimated that about 12 million people are chronically infected with hepatitis C in India.
Additional hepatitis C arrangements with Gilead comprise:
- A licensing and technology transfer agreement that grants Mylan the non-exclusive rights to manufacture and distribute generic sofosbuvir and generic ledipasvir/sofosbuvir and, upon FDA approval, the investigational NS5A inhibitor GS-5816 and single tablet regimen of sofosbuvir/GS-5816 in 91 developing countries
- An exclusivity for distribution of Gilead’s brand Harvoni® (ledipasvir 90mg/sofosbuvir 400 mg tablets) in India
Mylan N.V., through its auxiliaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company provides generic or branded generic pharmaceutical products in tablet, capsule, injectable, or transdermal patch forms, in addition to active pharmaceutical ingredients (APIs).
Shares of Realogy Holdings Corp. (NYSE:RLGY), declined -1.13% to $47.28, during its last trading session, hitting its highest level.
Realogy Holdings, stated financial results for the first quarter ended March 31, 2015, counting the following highlights:
- Revenue of $1.1 billion, which represents a 5% enhance contrast to first quarter 2014, was driven by higher homesale transaction volume.
- Adjusted EBITDA was $70 million, contrast to $53 million in the first quarter of 2014, a year-over-year enhance of 32%.
- Net loss for first quarter 2015 was $32 million, and basic loss per share was $0.22.
- Realogy’s franchise (RFG) and company-owned (NRT) business segments achieved a 10% enhance in combined homesale transaction volume (transaction sides multiplied by average sale price) contrast to first quarter 2014. RFG and NRT stated homesale transactions enhances of 4% and 6% and average homesale price enhances of 6% and 3%, respectively.
Realogy Holdings Corp. provides real estate and relocation services worldwide. The company’s Real Estate Franchise Services segment franchise its real estate brokerage franchise systems under the Century 21, Coldwell Banker, Coldwell Banker Commercial, ERA, Sotheby’s International Realty, and Better Homes and Gardens Real Estate brand names to real estate brokerage businesses.
At the end of Monday’s trade, Shares of TripAdvisor Inc. (NASDAQ:TRIP), dipped -1.13% to $79.91.
Today, TripAdvisor revealed its Summer Vacation Value Report, a resource identifying the top 10 destinations for U.S. travelers this summer, together with the average one-week costs for hotels, airfare, and meals. The report also assists travelers discover summer savings at these destinations, by highlighting the least expensive week to visit, highly-rated value hotels, inexpensive eateries and outstanding free attractions.
“Ninety percent of U.S. respondents are planning a getaway this summer according to a recent TripAdvisor survey,” said Brooke Ferencsik, director of communications for TripAdvisor. “Travelers appear eager to take advantage of the strong U.S. dollar by planning trips abroad, as six of the 10 most-searched destinations on TripAdvisor for summer travel are located outside the U.S.”
TripAdvisor, Inc. operates as an online travel company. The company operates through two segments, Hotel and Other. Its travel research platform aggregates reviews and opinions about accommodations, destinations, activities and attractions, and restaurants that enable consumers to plan and book hotels, vacation rentals, flights, activities and attractions, and restaurants.
Finally, Himax Technologies, Inc. (NASDAQ:HIMX), ended its last trade with -1.13% loss, and closed at $6.15.
Himax Technologies, will hold a conference call with investors and analysts on Thursday, May 14, 2015 at 8:00 a.m. US Eastern Daylight Time and 8:00 p.m. Taiwan Time to talk about the Company’s first quarter 2015 financial results.
Himax Technologies, Inc., a fabless semiconductor company, provides display imaging processing technologies to consumer electronics worldwide. The company operates through Driver IC and Non-Driver Products segments.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
